Key Record Dates
ClinicalTrials.gov Identifier: | NCT02964013 |
---|---|
Brief Title: | Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) |
First Submitted : | November 11, 2016 |
First Submitted that Met QC Criteria : | November 11, 2016 |
First Posted : | November 15, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | April 22, 2022 |
Last Update Posted : | April 25, 2022 |